Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Regulation of cyclin T1 during HIV replication and latency establishment in human memory CD4 T cells.

Couturier J, Orozco AF, Liu H, Budhiraja S, Siwak EB, Nehete PN, Sastry KJ, Rice AP, Lewis DE.

Virol J. 2019 Feb 20;16(1):22. doi: 10.1186/s12985-019-1128-6.

2.

Crosstalk between histone modifications indicates that inhibition of arginine methyltransferase CARM1 activity reverses HIV latency.

Zhang Z, Nikolai BC, Gates LA, Jung SY, Siwak EB, He B, Rice AP, O'Malley BW, Feng Q.

Nucleic Acids Res. 2017 Sep 19;45(16):9348-9360. doi: 10.1093/nar/gkx550.

3.

The Human Immune Response to HIV and its Impact in the Potential Development of an Inactivated HIV Vaccine.

Rios A, Pottet EC, Siwak EB, Anderson DW, Yao QC.

AIDS Rev. 2016 Jul-Sep;18(3):151-157. Review.

PMID:
27438575
5.

HIV inactivation: time for a second look.

Rios A, Poteet EC, Siwak EB, Anderson DW, Yao QC.

AIDS. 2015 Jan 2;29(1):129-31. doi: 10.1097/QAD.0000000000000522. No abstract available.

PMID:
25562498
6.

Mycoplasma genitalium promotes epithelial crossing and peripheral blood mononuclear cell infection by HIV-1.

Das K, De la Garza G, Siwak EB, Scofield VL, Dhandayuthapani S.

Int J Infect Dis. 2014 Jun;23:31-8. doi: 10.1016/j.ijid.2013.11.022. Epub 2014 Mar 21.

7.

Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro.

Lü JM, Yan S, Jamaluddin S, Weakley SM, Liang Z, Siwak EB, Yao Q, Chen C.

Med Sci Monit. 2012 Aug;18(8):BR293-298.

8.

Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.

Thippeshappa R, Polacino P, Yu Kimata MT, Siwak EB, Anderson D, Wang W, Sherwood L, Arora R, Wen M, Zhou P, Hu SL, Kimata JT.

J Virol. 2011 Apr;85(8):3767-79. doi: 10.1128/JVI.02438-10. Epub 2011 Feb 2.

9.

Dendritic cell-mediated HIV-1 infection of T cells demonstrates a direct relationship to plasma viral RNA levels.

Arora R, Bull L, Siwak EB, Thippeshappa R, Arduino RC, Kimata JT.

J Acquir Immune Defic Syndr. 2010 Jun;54(2):115-21. doi: 10.1097/QAI.0b013e3181daaf98.

10.

Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy.

Nance CL, Siwak EB, Shearer WT.

J Allergy Clin Immunol. 2009 Feb;123(2):459-65. doi: 10.1016/j.jaci.2008.12.024.

11.

WITHDRAWN: Very strong synergy between modified RANTES and gp41 binding peptides leads to potent anti-HIV-1 activity.

Jin H, Siwak EB, Smith R, Liwang PJ.

Antimicrob Agents Chemother. 2009 Aug 31. [Epub ahead of print]

PMID:
18663025
12.

Human parvovirus B19 in young male patients with hemophilia A: associations with treatment product exposure and joint range-of-motion limitation.

Soucie JM, Siwak EB, Hooper WC, Evatt BL, Hollinger FB; Universal Data Collection Project Working Group.

Transfusion. 2004 Aug;44(8):1179-85.

PMID:
15265122
13.

Transendothelial migration of leukocytes carrying infectious HIV-1: an indicator of adverse prognosis.

Birdsall HH, Siwak EB, Trial J, Rodriguez-Barradas M, White AC Jr, Wietgrefe S, Rossen RD.

AIDS. 2002 Jan 4;16(1):5-12.

PMID:
11741157
14.

Long-term culture of human immunodeficiency virus type 1 resulting in loss of glycosylation sites.

Lin HJ, Siwak EB, Lauder IJ, Hollinger FB.

J Med Virol. 2001 Mar;63(3):197-202.

PMID:
11170057
15.

Co-receptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient?

Lathey JL, Brambilla D, Goodenow MM, Nokta M, Rasheed S, Siwak EB, Bremer JW, Huang DD, Yi Y, Reichelderfer PS, Collman RG.

J Leukoc Biol. 2000 Sep;68(3):324-30.

PMID:
10985247
16.

[Cerebrospinal fluid serotonin concentration in pyogenic and tick-borne encephalomeningitis].

Siwak EB, Pawlak D, Buczko W, Kondrusik M, Hermanowska-Szpakowicz T.

Neurol Neurochir Pol. 1999 Mar-Apr;33(2):339-49. Polish.

PMID:
10463248
17.

Selection of appropriate HIV-1 genomic regions for single-strand conformation polymorphism analysis of the diversity, modification, and transmission of HIV-1 quasispecies.

Lin HJ, Siwak EB, Lauder IJ, Hollinger FB.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15;18(5):409-16.

PMID:
9715836
18.

Transendothelial migration of lymphocytes from HIV-1-infected donors: a mechanism for extravascular dissemination of HIV-1.

Birdsall HH, Trial J, Lin HJ, Green DM, Sorrentino GW, Siwak EB, de Jong AL, Rossen RD.

J Immunol. 1997 Jun 15;158(12):5968-77.

PMID:
9190951
19.

Kernel density analysis of variable and conserved regions of the envelope proteins of human immunodeficiency virus type 1 and associated epitopes.

Lauder IJ, Lin HJ, Siwak EB, Hollinger FB.

AIDS Res Hum Retroviruses. 1996 Jan 20;12(2):91-97.

PMID:
8834458
20.

Analysis of sewage effluent for human immunodeficiency virus (HIV) using infectivity assay and reverse transcriptase polymerase chain reaction.

Palmer CJ, Lee MH, Bonilla GF, Javier BJ, Siwak EB, Tsai YL.

Can J Microbiol. 1995 Sep;41(9):809-15.

PMID:
7585358
22.

Anti-idiotype-based vaccines against biological toxins.

Chanh TC, Siwak EB, Hewetson JF.

Toxicol Appl Pharmacol. 1991 Apr;108(2):183-93. Review.

PMID:
2017749
23.

Effect of sunlight on survival of indicator bacteria in seawater.

Fujioka RS, Hashimoto HH, Siwak EB, Young RH.

Appl Environ Microbiol. 1981 Mar;41(3):690-6.

Supplemental Content

Loading ...
Support Center